ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q3SCImago #22,052SubscriptionDomestic Journal

Chinese Traditional and Herbal Drugs

Identifier (ISSN):0253-2670(Print)
•
Publisher:Chung Tsao Yao Tsa Chih Pien Chi Pu
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Chinese Traditional and Herbal Drugs

WoS Q1
000002025
Annual Impact Factor Metric
Current (2025):0
Scopus SJR & RankScopus Q3
0.198
#22,052

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
30

30 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
3articles/year
0% Gold OA•0% Original Research

Aims & Scope

hinese Traditional and Herbal Drugs, a monthly journal with “zhongcaoyao” as Chinese name, the initial issue was distributed in January, 1970 and its ISSN is 0253-2670. The journal is an academic and technical journal sponsored by Chinese Pharmaceutical Association and Tianjin Institute of Pharmaceutical Research (TIPR). The journal, which has a long history of 41 years, offers the columns of research papers, brief reports, reviews, dissertation, and special treatises to report the recent achievements of our basic study, production, quality control, and clinic application on traditional Chinese medicine and Chinese materia medica. The editorial committee consists of over one hundred of specialists with a great academic attainment in pharmaceutical research, education, production, quality control, and clinic application.

Topics Covered (Recognized by AI)
Chemistry83.6%Biology82.4%Medicine67.8%Biochemistry53%Organic chemistry52%Chromatography45.2%Botany39.3%Genetics34.7%Traditional medicine33.1%Physics32.5%Pathology28.9%Internal medicine24.3%Materials science22.9%Alternative medicine22.8%Pharmacology20.7%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year
2025Latest
IF0
Articles / Year—
Total Citations—
2021
IF—
Articles / Year3
Total Citations4
2020
IF—
Articles / Year25
Total Citations164
2019
IF—
Articles / Year4
Total Citations3
2018
IF—
Articles / Year6
Total Citations8

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #22,052Scopus Q3SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.198

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.97

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,395 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,309
3-Year Documents2,458
Citable Documents2,458

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Complementary and Alternative MedicineQ3
Pharmaceutical ScienceQ3
Drug DiscoveryQ4
Pharmacology (medical)Q4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Chinese Traditional and Herbal Drugs (ISSN: 0253-2670) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Chung Tsao Yao Tsa Chih Pien Chi Pu in China. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.198 (Q3), an H-index of 30.

The journal enforces rigorous peer evaluation with an annual output of approximately 3 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,395 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Chung Tsao Yao Tsa Chih Pien Chi Pu
Publication Language
English
Frequency
Periodic
Indexing & Databases
ScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 05e7c99b-c0fd-4fc7-b1a8-ec3c57bf0655
Database Updated: 2026-10-01